Maggiore Christopher D.'s Form 4 filing
Zivo Bioscience, Inc. (ZIVO) · filed Feb 16, 2022
- Accession no.
- 0001654954-22-001719
- Filed
- Feb 16, 2022
- Trade date
- Feb 9-11, 2022
- Filing delay
- 7 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market purchases total $340.2K. It was filed 7 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maggiore Christopher D.CIK 0001436075 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2022 | Common Stock | PPurchaseAcquired | +28,363 | $3.55F1 | +$100,688.65 | 740,134 | Direct | |
| Feb 10, 2022 | Common Stock | PPurchaseAcquired | +18,006 | $3.64F2 | +$65,541.84 | 758,140 | Direct | |
| Feb 11, 2022 | Common Stock | PPurchaseAcquired | +44,965 | $3.87F3 | +$174,014.55 | 803,105 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
(1)The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.4899 to $3.60 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F2
(2)The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.48 to $3.70 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F3
(3)The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.7199 to $4.07 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.